Citations Report

Clinical Investigation : Citations & Metrics Report

Articles published in Clinical Investigation have been cited by esteemed scholars and scientists all around the world.

Clinical Investigation has got h-index 28, which means every article in Clinical Investigation has got 28 average citations.

Following are the list of articles that have cited the articles published in Clinical Investigation.

• Ghobrial IM, Campigotto F, Murphy TJ, Boswell EN, Banwait R, et al. (2013) Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia. Blood121:1296-303 View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2015) Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders. United States patent US 9,220,755 View at Publisher | View at Google Scholar | View at Indexing
• Schrum JP, Bancel S, Afeyan NB, Ejebe K, inventors; Moderna Therapeutics, et al. (2016) Engineered nucleic acids and methods of use thereof. United States patent US 9,447,164 View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, Weiss R, inventors; Moderna Therapeutics, Inc (2015) Modified polynucleotides for treating galactosylceramidase protein deficiency. United States patent US 9,089,604 View at Publisher | View at Google Scholar | View at Indexing
• De Fougerolles A, Elbashir SM, inventors; Modernatx, Inc (2017) Delivery and formulation of engineered nucleic acids. United States patent US 9,533,047 View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2015) Modified polynucleotides encoding aquaporin-5. United States patent US 9,220,792 View at Publisher | View at Google Scholar | View at Indexing

• Lim E, Tarulli G, Portman N, Hickey TE, Tilley WD, et al. (2016) Pushing estrogen receptor around in breast cancer. Endocrine-related cancer 23: T227-T241.

  View at Publisher | View at Google Scholar
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2015) Modified polynucleotides encoding basic helix-loop-helix family member E41. United States patent US 9,107,886 View at Publisher | View at Google Scholar | View at Indexing
• Pietri E, Conteduca V, Andreis D, Massa I, Melegari E, et al. (2016) Androgen receptor signaling pathways as a target for breast cancer treatment. Endocrine-Related Cancer 23: R485-R498. View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2016) Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders. United States patent US 9,233,141 View at Publisher | View at Google Scholar | View at Indexing
• Machaj AS (2014) Breast Cancer in PTEN Hamartoma Tumor Syndrome: Can a Predictive Fingerprint be Identified? (Doctoral dissertation, Case Western Reserve University). View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, Weiss R, inventors; Moderna Therapeutics, Inc (2015) Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator. United States patent US 9,050,297 View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2015) Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1. United States patent US 9,095,552 View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2016) Modified polynucleotides encoding apoptosis inducing factor 1. United States patent US 9,301,993 View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2015) Modified polynucleotides encoding granulysin. United States patent US 9,216,205 View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2016) Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1. United States patent US 9,255,129 View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2015) Modified polynucleotides encoding citeD4. United States patent US 9,114,113 View at Publisher | View at Google Scholar | View at Indexing
• Bancel S, Chakraborty T, De Fougerolles A, Elbashir SM, John M, et al. (2015) Modified polynucleotides for the production of biologics and proteins associated with human disease. United States patent US 8,999,380 View at Publisher | View at Google Scholar | View at Indexing
• Hensel M, Brust J, Plöger C, Schuster D, Memmer ML, et al. (2012) Excellent long-term survival of 170 patients with Waldenström’s macroglobulinemia treated in private oncology practices and a university hospital. Annals of hematology91:1923-8 View at Publisher | View at Google Scholar | View at Indexing
• D'souza A, Ansell S, Reeder C, Gertz MA (2013) Waldenström macroglobulinaemia: the key questions. British journal of haematology162:295-303 View at Publisher | View at Google Scholar | View at Indexing

• Coimbra S, Neves R, Lima M, Belo L, Santos-Silva A (2014) Waldenström's macroglobulinemia-a review. Revista da Associação Médica Brasileira60:490-9

  View at Publisher | View at Google Scholar
• Schrum JP, Siddiqi S, Ejebe K, inventors; Moderna Therapeutics, Inc (2016) Modified nucleosides, nucleotides, and nucleic acids, and uses thereof. United States patent US 9,334,328 View at Publisher | View at Google Scholar | View at Indexing
• Hoge SG, De Fougerolles A, Ellsworth JL, inventors; Moderna Therapeutics, Inc (2015) Compositions and methods of altering cholesterol levels. United States patent US 8,980,864 View at Publisher | View at Google Scholar | View at Indexing
• Bancel S, Chakraborty T, De Fougerolles A, Elbashir SM, John M, et al. (2016) United States patent US 9,254,311. View at Publisher | View at Google Scholar | View at Indexing
• De Fougerolles A, Elbashir SM, inventors; Moderna Therapeutics, Inc (2015) Split dose administration. United States patent US 9,186,372 View at Publisher | View at Google Scholar | View at Indexing
• Vuorio A, Tikkanen MJ, Kovanen PT (2014) inhibition of hepatic microsomal triglyceride transfer protein–a novel therapeutic option for treatment of homozygous familial hypercholesterolemia. Vascular health and risk management 10: 263. View at Publisher | View at Google Scholar | View at Indexing
• Vorsanger M, Underberg JA (2013) New Treatment Approaches for Dyslipidemia and its Management. Current Cardiovascular Risk Reports 7: 395-400. View at Publisher | View at Google Scholar | View at Indexing
• Enck P, Grundy D, Klosterhalfen S (2012) A novel placebo-controlled clinical study design without ethical concerns–The free choice paradigm. Medical hypotheses 79: 880-882. View at Publisher | View at Google Scholar | View at Indexing
• Steinvorth SM, Röver C, Schneider S, Nicholas R, Straube S, et al. (2013) Explaining temporal trends in annualised relapse rates in placebo groups of randomised controlled trials in relapsing multiple sclerosis: systematic review and meta-regression. Multiple Sclerosis Journal 19: 1580-1586. View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2016) Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins. United States patent US 9,303,079 View at Publisher | View at Google Scholar | View at Indexing
• Schneider S, Schmidli H, Friede T (2013) Blinded sample size reâ€Âestimation for recurrent event data with time trends. Statistics in medicine 32: 5448-5457. View at Publisher | View at Google Scholar | View at Indexing
• Schneider S, Schmidli H, Friede T (2013) Blinded and unblinded internal pilot study designs for clinical trials with count data. Biometrical Journal 55: 617-633. View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, Weiss R, inventors; Moderna Therapeutics, Inc (2015) Modified polynucleotides for treating protein deficiency. United States patent US 9,061,059 View at Publisher | View at Google Scholar | View at Indexing

• Mütze T, Munk A, Friede T (2016) Design and analysis of three‐arm trials with negative binomially distributed endpoints. Statistics in medicine 35: 505-521.

  View at Publisher | View at Google Scholar

• Friede T, Mütze T. Gold Standard Designs for Clinical Trials with Overdispersed Count Data.

  View at Publisher | View at Google Scholar
• Mütze T, Munk A (2013) Design and analysis of clinical non-inferiority trials with active and placebo control for count data. View at Publisher | View at Google Scholar | View at Indexing
• De Fougerolles A, Wood KM, Valencia P, inventors; Moderna Therapeutics, Inc (2016) Formulation and delivery of PLGA microspheres. United States patent US 9,295,689 View at Publisher | View at Google Scholar | View at Indexing
• Bancel S, Schrum JP, Aristarkhov A, inventors; Moderna Therapeutics, Inc (2016) Engineered nucleic acids and methods of use thereof. United States patent US 9,464,124 View at Publisher | View at Google Scholar | View at Indexing
• Jiang YH, Liu HT, Kuo HC (2014) Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid. PloS one 9: e91609. View at Publisher | View at Google Scholar | View at Indexing
• Jiang YH, Kuo HC (2014) Urothelial Dysfunction and Increased Suburothelial Inflammation of Urinary Bladder Are Involved in Patients with Upper Urinary Tract Urolithiasis–Clinical and Immunohistochemistry Study. PloS one 9: e110754. View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, Weiss R, inventors; Moderna Therapeutics, Inc (2016) Modified polynucleotides for the production of nuclear proteins. United States patent US 9,283,287 View at Publisher | View at Google Scholar | View at Indexing
•   Véronique Leblond,  Giampaolo Merlini,  Steven P. Treon Scott Rodig,  Jan Delabie.  Waldenström’s Macroglobulinemia   View at Publisher | View at Google Scholar | View at Indexing

• Merrett ND (2014) Multimodality treatment of potentially curative gastric cancer: geographical variations and future prospects. World Journal of Gastroenterology: WJG 20:12892.

  View at Publisher | View at Google Scholar
• Yoo C, Ryu MH, Park YS, Yoo MW, Park SR, Ryoo BY, Jang SJ, Yook JH, Kim BS, Kang YK. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence. Annals of surgical oncology 22: 2940-2947. View at Publisher | View at Google Scholar | View at Indexing
• Yoon S, Yoo C, Ryu MH, Kang MJ, Ryoo BY, et al. (2017) Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer. Gastric Cancer 20: 182-189. View at Publisher | View at Google Scholar | View at Indexing

• Leblond V, Merlini G, Treon SP, Rodig S, Delabie J (2015) Waldenström’s Macroglobulinemia. In: Rare Lymphomas. Springer Berlin Heidelberg

  View at Publisher | View at Google Scholar
• Merrett ND, Merrett ND (2014) Multimodality treatment of potentially curative gastric cancer: Geographical variations and future prospects. View at Publisher | View at Google Scholar | View at Indexing
• Schrum JP, Bancel S, Afeyan NB, inventors; Moderna Therapeutics, Inc (2015) Engineered nucleic acids and methods of use thereof. United States patent US 9,181,319 View at Publisher | View at Google Scholar | View at Indexing
• Chakraborty T, De Fougerolles A, inventors; Moderna Therapeutics, Inc (2015) Modified polynucleotides encoding septin-4. United States patent US 9,149,506 View at Publisher | View at Google Scholar | View at Indexing
• Hong P, Liu Y, Li H (2015) Comparison of the efficacy and safety between interspinous process distraction device and open decompression surgery in treating lumbar spinal stenosis: a meta analysis. Journal of Investigative Surgery 28: 40-49. View at Publisher | View at Google Scholar | View at Indexing